Insights into cancer surveillance in C entral and E astern E urope, I srael and T urkey
Open Access
- 8 November 2013
- journal article
- research article
- Published by Wiley in European Journal of Cancer Care
- Vol. 24 (1) , 99-110
Abstract
The current cancer landscape within transitional economies in central and Eastern Europe and the Mediterranean area is not particularly optimistic. Current perceptions are often based on extrapolations from other countries and regions; and hence the authors collaborated with the South Eastern Europe Oncology Group (SEEROG) to collect information on cancer registration in Central and Eastern Europe, Israel and Turkey. Healthcare authorities and specialist oncology centres in 21 countries in the region were contacted for information on cancer registries in their countries. Based on this information, the authors believe that the recording and reporting of data on cancer in the region is at an acceptable level. The authors discuss and compare institution- and population-based registries, and present opinions on elements of an 'ideal registry' based on the survey replies and comparisons with other registries. A comparison with the sources used for GLOBOCAN 2008 illustrates the need for consistent data to be communicated, published and utilised throughout the region and the oncology community. The authors conclude by considering the potential value of collaboration between health authorities across the region, as well as between the clinical and epidemiological communities, to ensure that cancer data are consistently collected, verified and made public.Keywords
Funding Information
- Pfizer Oncology
- Pfizer
This publication has 24 references indexed in Scilit:
- Assessing the Real-World Cost-Effectiveness of Adjuvant Trastuzumab in HER-2/neu Positive Breast CancerThe Oncologist, 2012
- Estimates of cancer incidence and mortality in Europe in 2008European Journal of Cancer, 2010
- Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975Annals of Oncology, 2009
- EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentaryEuropean Journal of Cancer, 2009
- Verification of imatinib cost-effectiveness in advanced gastrointestinal stromal tumor in British Columbia (VINCE-BC study)Journal of Oncology Pharmacy Practice, 2008
- Stage-Specific Effect of Adjuvant Therapy Following Gastric Cancer Resection: a Population-based Analysis of 4,041 PatientsAnnals of Surgical Oncology, 2007
- The British Society for Rheumatology Biologics RegisterAnnals of the Rheumatic Diseases, 2005
- Trends and patterns of cancer mortality in European countriesEuropean Journal Of Cancer Prevention, 2003
- The European Community expansion and cancer burdenEuropean Journal Of Cancer Prevention, 2003
- Testicular cancer mortality in Eastern EuropeInternational Journal of Cancer, 2003